BMA reverses opposition to Cass review on NHS youth gender care

The British Medical Association (BMA) has reversed its stance on the Cass review, a major assessment of NHS gender identity services for children and young people. Previously, the BMA had opposed the findings, calling them 'unsubstantiated'. Now, after a fresh internal review, it no longer stands against the recommendations.

The Cass review, led by Dr. Hilary Cass, examined gender identity care within the NHS. It found that services were 'built on shaky foundations' due to a lack of strong evidence. The report also warned that medical interventions, such as sex hormones for under-18s, lacked sufficient proof of safety and effectiveness.

The BMA initially rejected the review’s 32 recommendations, refusing to endorse them. However, a new assessment by 12 union members has led to a change in position. Professor David Strain, chair of the BMA’s board of science, described the process as constructive and respectful. Strain noted that clinicians with differing opinions had engaged thoughtfully. He also highlighted that the evidence was carefully reviewed, with respect for both the data and the ethical challenges involved.

The BMA’s shift means it no longer opposes the Cass review’s recommendations. The review had raised concerns about the lack of robust evidence supporting current gender care practices for young people. This change could influence how NHS services for under-18s are structured in the future.